GUTS
NASDAQ
$0.78
Fractyl Health Inc (GUTS)
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company is headquartered in Lexington, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $5.03 (+544.21%)
Market Cap
$144M
Free Cash Flow Yield
-60.84%
Beta (5Y)
1.17
Price Chart
Valuation
Market Cap$144M
P/S7575.74
P/B5.94
Profitability
Gross Profit (TTM)$3K
EBITDA-$92M
EPS-$0.83
Financial Health
Free Cash Flow Yield-60.84%
Growth & Risk
Beta (5Y)1.17
Sharpe Ratio0.11